Skip to main content

About the NCI Council of Research Advocates

The Office of Advocacy Relations (OAR) manages the NCI Council of Research Advocates (NCRA), the only federal advisory committee comprised solely of advocate leaders at NCI. NCRA  convenes around broad cancer research issues and provides the Director with advice and strategic insights from the community's perspective.

NCRA members are selected for their expert knowledge of cancer research and policy, as well as their ability to represent a broad patient perspective.

Prior NCRA meeting agendas and summaries can be found through the NCI Division of Extramural Activities.

Chair

Anjelica Q. Davis
2022
President
Fight Colorectal Cancer
Springfield, Missouri

Members

Melinda Bachini
2024
Advocacy Coordinator
Cholangiocarcinoma Foundation
Herriman, Montana
 
Yelak S. Biru
2023
CEO
International Myeloma Foundation
North Hollywood, California
 
Victoria Buenger, Ph.D.
2025
Clinical Professor
Department of Management
Mays School of Business
Texas A&M University
College Station, Texas
 
Melissa F. Buffalo
2025
Chief Executive Officer
American Indian Cancer Foundation
Minneapolis, Minnesota
 
Annie Ellis
2024
Research Advocate
Gynecologic Cancer Steering Committee
Ovarian Cancer Research Alliance
New York, New York
 
Jennifer W. Pegher
2022
Executive Director
Association of American Cancer Institutes
Pittsburgh, Pennsylvania
 
Kristen C. Santiago
2023
Senior Director
Public Policy Initiatives
LUNGevity
Bethesda, Maryland
 
Jacqueline D. Smith
2024
Director of Patient Advocacy
Vertex Pharmaceuticals
Boston, Massachusetts
 
Kevin J. Stemberger
2024
Research Advocate
Co-Founder and Partner
Noble Capital Partners, LLC
Farmington Hills, Michigan
 
Nicole E. Willmarth, Ph.D.
2023
Chief Mission Officer
American Brain Tumor Association
Chicago, Illinois

 

  • Updated: